Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 


Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Feb 21, 2023

Scott Gray is the President and CEO of Clincierge and supporting the activities related to the observation of Rare Disease Day on February 28. Clincierge is focused on coordinating logistical, financial, caregiving, and translation services to facilitate participation in clinical trials by patients with rare diseases. With a personalized, local approach, they support sponsors of research in the recruitment and retention of patients by removing obstacles and reducing stress.

Scott explains, "The intent is to provide an energy and a focal point that enables rare disease advocacy work to progress on the local, national, and international levels. The intent of improving access to treatment and medical representation for the many individuals who struggle with a rare disease and include their families who support and care for them. Since it was created in 2008, Rare Disease Day has played a critical part in building an international rare disease community that is multi-disease, global, and diverse but truly united in its purpose of expanding access for these unique patients."

"From what we've observed in the rare disease space, there hasn't been a great effect by technology. Monitoring can happen, but a lot of the observational reviews that have to happen during the visit are only able to happen with going to the site. During the pandemic, as you mentioned, we were asked in some instances to move the healthcare provider to the home of the rare disease patient so that they didn't have to travel, especially if it was a patient who was immunocompromised. And if that wasn't possible, there were also instances where the sponsor budgeted for private jet travel so that an immunocompromised patient could visit the site."

@Clincierge #RareDiseaseDay #ShowYourStripes #RareDiseases #ClinicalTrials

Listen to the podcast here